参考文献/References:
[1] Xue J, Jia X, Li J,et al. Description of the thyroid hormone resistance syndrome illustrated by such a case, which had two different carcinomas and was mistreated with iodine-131[J]. Hell J Nucl Med,2015,18(3):247-251.
[2] Lai S, Zhang S, Wang L,et al. A rare mutation in patients with resistance to thyroid hormone and review of therapeutic strategies[J]. Am J Med Sci, 2015,350(3):167-174. DOI: 10.1097/MAJ.0000000000000538.
[3] Han R, Ye L, Jiang X, et al. Characteristics of patients with late manifestation of resistance thyroid hormone syndrome: a single-centerexperience[J]. Endocrine, 2015,50(3):689-697.DOI:10.1007/s12020-015-0622-x.
[4] Gonçalves AP, Aragüés JM, Nobre E,et al. A case of thyroid hormone resistance: a rare mutation[J].Arq Bras Endocrinol Metabol,2014,58(9):962-966. DOI: 10.1590/0004-2730000003297.
[5] Vlaeminck-Guillem V, Espiard S, Flamant F, et al. TRα receptor mutations extend the spectrum of syndromes of reduced sensitivity to thyroid hormone[J]. Presse Med, 2015,44(11):1103-1112. DOI: 10.1016/j.lpm.2015.07.022.
[6] Visser WE, van Mullem AA, Visser TJ,et al. Different causes of reduced sensitivity to thyroid hormone: diagnosis and clinical management[J].Clin Endocrinol(Oxf), 2013,79(5):595-605. DOI: 10.1111/cen.12281.
[7] Karakose M, Caliskan M, Arslan MS,et al. Thyroid hormone resistance in two patients with papillary thyroid microcarcinoma and their BRAFV600E mutation status[J].Arch Endocrinol Metab, 2015,59(4):364-366. DOI: 10.1590/2359-3997000000091.
[8] Chen K, Xie Y, Zhao L, et al. A novel mutation of thyroid hormone receptor β in exon 10 in a case of thyroid hormone-resistant non-Hodgkin's lymphoma of the thyroid[J].Oncol Lett, 2015,9(2):614-618. DOI:10.3892/ol.2014.2715.
[9] Zhao W, Yin J, Yang Z, et al. Meta-analysis of androgen insensitivity in preoperative hormone therapy in hypospadias[J].Urology,2015,85(5):1166-1172. DOI: 10.1016/j.urology.2015.01.035.
[10] Konar S, Dasgupta D, Patra DK,et al. Chromosomal study is must for prepubertal girl with inguinal hernia: opportunity to diagnose complete androgen insensitivity syndrome[J]. J Clin Diagn Res, 2015,9(4):GD01-GD03. DOI: 10.7860/JCDR/2015/11411.5750.
[11] Mongan NP, Tadokoro-Cuccaro R, Bunch T, et al. Androgen insensitivity syndrome[J].Best Pract Res Clin Endocrinol Metab,2015,29(4):569-580. DOI: 10.1016/j.beem.2015.04.005.
[12] Tadokoro-Cuccaro R, Davies J, Mongan NP, et al. Promoter-dependent activity on androgen receptor N-terminal domain mutations in androgen insensitivity syndrome[J].Sex Dev,2014,8(6):339-349. DOI: 10.1159/000369266.
[13] 张曼娜,李小英. 雄激素不敏感综合征与代谢综合征[J].中国实用内科杂志, 2011,31(4):269-270.DOI:1005-2194(2011)04-0269-02.
[14] Hoefgen HR, Merritt DF. Invasive deuctal carcinoma in a 46,XY partial androgen insensitivity syndrome patient on hormone therapy[J].J Pediatr Adolesc Gynecol,2015,28(4):e95-e97. DOI: 10.1016/j.jpag.2014.08.005.
[15] 崔正慧,金杭美.睾丸女性化综合征的研究进展[J].中国妇幼健康研究, 2006,17(6):547-549. DOI:1673-5293(2006)06-0547-03.
[16] Underbjerg L, Sikjaer T, Mosekilde L,et al. Pseudohypoparathyroidism-epidemiology, mortality and risk of complications[J].Clin Endocrinol(Oxf), 2016,84(6):904-911.DOI: 10.1111/cen.12948.
[17] Zhu J, Wang D, Ren A,et al. Abnormal methylation status of the GNAS exon 1A region in pseudohypohyperparathyroidism combined with Turner syndrome[J].Am J Med Sci,2015,350(6):458-462. DOI: 10.1097/MAJ.0000000000000589.
[18] 项坤三.全身性和局部性脂肪营养不良症//项坤三编.特殊类型糖尿病[M].上海:科学技术出版社, 2011:289-302.
[19] Choi JH, Kang M, Kim JH,et al. Identification and functional characterization of two novel nonsense mutations in the β-subunit of INSR that cause severe insulin resistance syndrome[J].Horm Res Paediatr,2015,84(2):73-78. DOI: 10.1159/000381624.
相似文献/References:
[1]周庆菊,李蓉.MODY2的认识及诊疗进展[J].国际内分泌代谢杂志,2016,36(03):180.[doi:10.3760/cma.j.issn.1673-4157.2016.03.09]
Zhou Qingju,Li Rong..The cognition, diagnosis and treatment of MODY2[J].International Journal of Endocrinology and Metabolism,2016,36(01):180.[doi:10.3760/cma.j.issn.1673-4157.2016.03.09]
[2]郭曼丽,李伟,马绍刚,等.甲状腺过氧化物酶基因c.2268dupT突变与甲状腺结节的相关性研究[J].国际内分泌代谢杂志,2017,37(04):232.
Guo Manli*,Li Wei,Ma Shaogang,et al.Relationship between c.2268dupT mutation in thyroid peroxidase gene and thyroid nodules[J].International Journal of Endocrinology and Metabolism,2017,37(01):232.
[3]游晶玉,罗飞宏.单基因糖尿病的研究进展[J].国际内分泌代谢杂志,2017,37(04):266.
You Jingyu,Luo Feihong..Recent progress of monogenic diabetes[J].International Journal of Endocrinology and Metabolism,2017,37(01):266.
[4]王慧萍,童安莉.原发性醛固酮增多症相关的基因突变研究进展[J].国际内分泌代谢杂志,2021,41(02):87.[doi:10.3760/cma.j.cn121383-20200706-07013]
Wang Huiping,Tong Anli..Research progress on gene mutation related primary aldosteronism[J].International Journal of Endocrinology and Metabolism,2021,41(01):87.[doi:10.3760/cma.j.cn121383-20200706-07013]
[5]彭雅洁,朱文娇,施缘萍,等.DNA损伤修复和遗传缺陷导致的脂肪分化异常及胰岛素抵抗的研究进展[J].国际内分泌代谢杂志,2022,42(03):219.[doi:10.3760/cma.j.cn121383-20210120-01056]
Peng Yajie,Zhu Wenjiao,Shi Yuanping,et al.Abnormal adipose differentiation and insulin resistance caused by DNA damage repair and genetic defects[J].International Journal of Endocrinology and Metabolism,2022,42(01):219.[doi:10.3760/cma.j.cn121383-20210120-01056]
[6]中华医学会内分泌学分会内分泌罕见病学组.葡萄糖激酶基因突变导致的单基因糖尿病诊治专家共识[J].国际内分泌代谢杂志,2022,42(03):236.[doi:10.3760/cma.j.cn121383-20220107-01010]
Study Group of Endocrinology Rare Diseases,Chinese Society of Endocrinology.Diagnosis and management of monogenic diabetes caused by glucokinase gene mutations[J].International Journal of Endocrinology and Metabolism,2022,42(01):236.[doi:10.3760/cma.j.cn121383-20220107-01010]
[7]秦晓燕,师萍,管庆波,等.青少年发病的成年型糖尿病分子遗传学研究进展[J].国际内分泌代谢杂志,2022,42(05):382.[doi:10.3760/cma.j.cn121383-20210412-04032]
Qin Xiaoyan,Shi Ping,Guan Qingbo,et al.Advances in molecular genetics of maturity-onset diabetes of the young[J].International Journal of Endocrinology and Metabolism,2022,42(01):382.[doi:10.3760/cma.j.cn121383-20210412-04032]
[8]谢梦晨,郭洋洋,黄金慧,等.原发性醛固酮增多症基因型与临床表型关系的研究进展[J].国际内分泌代谢杂志,2023,43(03):216.[doi:10.3760/cma.j.cn121383-20220307-03015]
Xie Mengchen,Guo Yangyang,Huang Jinhui,et al.Association of genotype and clinical phenotype of primary aldosteronism[J].International Journal of Endocrinology and Metabolism,2023,43(01):216.[doi:10.3760/cma.j.cn121383-20220307-03015]
[9]刘海春 高洪波 李赟 李隆敏 邵玉军.基因突变对嗜铬细胞瘤/副神经节瘤临床特征及预后的影响[J].国际内分泌代谢杂志,2023,43(05):392.[doi:10.3760/cma.j.cn121383-20221029-10044]
Liu Haichun,Gao Hongbo,Li Yun,et al.Effect of gene mutations on clinical features and prognosis of pheochromocytoma/paraganglioma[J].International Journal of Endocrinology and Metabolism,2023,43(01):392.[doi:10.3760/cma.j.cn121383-20221029-10044]